Component
Cure rate and egg reduction rate in treated infection
Cure rate and egg reduction rate in treated infection. Species, exposure and limitations are retained in each linked claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
In 958 children randomly allocated to seven treatment groups, the efficacy of single-dose 300 milligrams of polymorph A was not different from the placebo control at the 0.05 level in both hookworm and Trichuris infections, while the egg reduction and cure rates of 300 and 500 milligrams of polymorph C were similar to each other though inferior to the standard 100 milligrams twice daily for three days.
Experimental context and source evidence
- availability_state
- biomarker_context Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/mebendazole-research/7939946.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "972b8bb36b68b1f40fba5f7bdb38668e9d1c40cba27ddeb19db16a3bcf29053d", "start_char": 0, "end_char": 698, "text_sha256": "972b8bb36b68b1f40fba5f7bdb38668e9d1c40cba27ddeb19db16a3bcf29053d"}
- experimental_model
- Randomised seven-arm trial in 958 schoolchildren in Southern Thailand
- exposure
- Single doses of 300 milligrams polymorph A, 300 and 500 milligrams polymorph C, against placebo and against 100 milligrams polymorph C twice daily for three days
- limitations
- The only human record here that varies the crystal form, with a placebo arm. It is a single-dose comparison and does not follow reinfection.
- nutrient_topic
- Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms. · Mebendazole
- organism
- Human
- plain_language
- In children, a full dose of the wrong crystal form worked no better than a sugar pill.
- primary_references
- [mbz-p7939946] Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections. (1993). https://pubmed.ncbi.nlm.nih.gov/7939946/
- tissue_or_cell_type
- Hookworm and Trichuris infection
- trigger_kind
- biomarker_context Imported condition classification; unverified.
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomised seven-arm trial in 958 schoolchildren in Southern Thailand · source_derived_draft · unverified_draft
### mbz-polymorph-a-equals-placebo In 958 children randomly allocated to seven treatment groups, the efficacy of single-dose 300 milligrams of polymorph A was not different from the placebo control at the 0.05 level in both hookworm and Trichuris infections, while the egg reduction and cure rates of 300 and 500 milligrams of polymorph C were similar to each other though inferior to the standard 100 milligrams twice daily for three days. Condition category: biomarker_context nutrient_topic: Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms. plain_language: In children, a full dose of the wrong crystal form worked no better than a sugar pill. organism: Human tissue_or_cell_type: Hookworm and Trichuris infection experimental_model: Randomised seven-arm trial in 958 schoolchildren in Southern Thailand limitations: The only human record here that varies the crystal form, with a placebo arm. It is a single-dose comparison and does not follow reinfection. exposure: Single doses of 300 milligrams polymorph A, 300 and 500 milligrams polymorph C, against placebo and against 100 milligrams polymorph C twice daily for three days evidence_span: {"source_cache": "artifacts/mebendazole-research/7939946.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "972b8bb36b68b1f40fba5f7bdb38668e9d1c40cba27ddeb19db16a3bcf29053d", "start_char": 0, "end_char": 698, "text_sha256": "972b8bb36b68b1f40fba5f7bdb38668e9d1c40cba27ddeb19db16a3bcf29053d"} [mbz-p7939946] Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections. (1993). https://pubmed.ncbi.nlm.nih.gov/7939946/
Complete structured claim and evidenceTesting the biological activity of the three polymorphic forms of mebendazole called A, B and C by median lethal dose in mice after oral and intraperitoneal administration and by anthelmintic effect against the enteral and parenteral phases of Trichinella spiralis, the polymorphic form A was the least toxic and the least effective, and use of polymorph C was judged advisable for oral treatment given its lower toxicity than form B and similar anthelmintic effect.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/mebendazole-research/3608627.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cf4b94d7b266abf376ded706272be7f440f6f46b82db5ee9c36d2c34af6e8825", "start_char": 0, "end_char": 608, "text_sha256": "cf4b94d7b266abf376ded706272be7f440f6f46b82db5ee9c36d2c34af6e8825"}
- experimental_model
- Median lethal dose and anthelmintic efficacy of three mebendazole polymorphs in mice
- exposure
- Polymorphs A, B and C given orally and intraperitoneally, against enteral and parenteral phases of infection
- limitations
- Tests toxicity and efficacy of the three solid forms in the same animals. Numerical values for the median lethal doses are not given in the abstract and are not assumed here.
- nutrient_topic
- Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms. · Mebendazole
- organism
- Mouse
- plain_language
- One crystal form of the same molecule barely poisons the mouse and barely touches the worm.
- primary_references
- [mbz-p3608627] Experimental chemotherapy and toxicity in mice of three mebendazole polymorphic forms. (1987). https://pubmed.ncbi.nlm.nih.gov/3608627/ DOI: 10.1159/000238506
- tissue_or_cell_type
- Whole body and Trichinella spiralis infection
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Median lethal dose and anthelmintic efficacy of three mebendazole polymorphs in mice · source_derived_draft · unverified_draft
### mbz-polymorph-a-is-inert Testing the biological activity of the three polymorphic forms of mebendazole called A, B and C by median lethal dose in mice after oral and intraperitoneal administration and by anthelmintic effect against the enteral and parenteral phases of Trichinella spiralis, the polymorphic form A was the least toxic and the least effective, and use of polymorph C was judged advisable for oral treatment given its lower toxicity than form B and similar anthelmintic effect. Condition category: normal nutrient_topic: Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms. plain_language: One crystal form of the same molecule barely poisons the mouse and barely touches the worm. organism: Mouse tissue_or_cell_type: Whole body and Trichinella spiralis infection experimental_model: Median lethal dose and anthelmintic efficacy of three mebendazole polymorphs in mice limitations: Tests toxicity and efficacy of the three solid forms in the same animals. Numerical values for the median lethal doses are not given in the abstract and are not assumed here. exposure: Polymorphs A, B and C given orally and intraperitoneally, against enteral and parenteral phases of infection evidence_span: {"source_cache": "artifacts/mebendazole-research/3608627.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cf4b94d7b266abf376ded706272be7f440f6f46b82db5ee9c36d2c34af6e8825", "start_char": 0, "end_char": 608, "text_sha256": "cf4b94d7b266abf376ded706272be7f440f6f46b82db5ee9c36d2c34af6e8825"} [mbz-p3608627] Experimental chemotherapy and toxicity in mice of three mebendazole polymorphic forms. (1987). https://pubmed.ncbi.nlm.nih.gov/3608627/ DOI: 10.1159/000238506
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.